Search clinical trials for: OncoSil

Total 305 results

OncoSil Medical Limited

Not yet recruiting

OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy (OSPRItaly)

Locally Advanced Pancreatic Adenocarcinoma
Chinese University of Hong Kong

Recruiting

EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.

Pancreatic Cancer | Endoscopic Ultrasound

Hong Kong
EMS
Luxbiotech

Completed

Efficacy and Safety of Neosil on Chronic Effluvium

Chronic Telogen Effluvium

Brazil
OncoSil Medical Limited

Completed

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane (PanCO)

Unresectable Locally Advanced Pancreatic Carcinoma

United Kingdom, Belgium, Australia
OncoSil Medical Limited

Completed

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel. (OncoPaC-1)

Unresectable Locally Advanced Pancreatic Carcinoma

United States
Catalysis SL

Completed

Evaluation of Oncoxin-Viusid® in Prostate Cancer

Prostate Cancer

Cuba
Catalysis SL

Completed

Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.

Mucositis Oral

Russian Federation
Catalysis SL

Completed

Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease

Breast Fibrocystic Disease

Cuba
Catalysis SL

Completed

Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

Cuba
Istanbul University - Cerrahpasa (IUC)

Recruiting

Effectiveness of Mobile Based Monitoring System in the Management of Chemotherapy-Related Symptoms

Cancer | Mobile Applications | Chemotherapeutic Toxicity

Turkey
Centre Leon Berard
Clinident Institute

Unknown

Evaluation of the Oncoral® Test in Epidermoid Carcinomas of the Upper Aerodigestive Tract

Carcinoma

France
Catalysis SL

Completed

Evaluation of Oncoxin-Viusid® in Head and Neck Cancer

Head Cancer Neck

Cuba
Clinical Research Organization, Dhaka, Bangladesh

Unknown

Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Bangladesh
Hospices Civils de Lyon

Recruiting

Medico-economic Evaluation of the ONCORAL Program for Ambulatory Patients Under Oral Anticancer Drugs Versus Usual Care (ONCORAL-PRME)

Cancer

France
Catalysis SL

Completed

Oncoxin® and Quality of Life in Cancer Patients

Non-small Cell Lung Cancer Stage III | Gastric Cancer Stage III | Gastric Cancer Stage II | Non-small Cell Lung Cancer Stage II

Kazakhstan, Russian Federation
Targovax Oy
Agenus Inc.

Withdrawn

A Study of ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients

Melanoma
Catalysis SL

Completed

Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.

Cervical Carcinoma Stage II | Cervical Carcinoma Stage III | Cervical Carcinoma Stage IV | Endometrial Adenocarcinoma Stage II | Endometrial Adenocarcinoma Stage III | Endometrial Adenocarcinoma Stage IV

Cuba
Hospital Militar Central Cirujano Mayor Dr. Cosme...
Instituto Nacional del Cáncer, Argentina

Recruiting

Oncoliq: Test for Early Breast Cancer Detection.

Breast Cancer

Argentina
Fidia Farmaceutici s.p.a.

Completed

ONCOFID-P-B in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder.

Non-Invasive Papillary Carcinoma of Bladder

Spain, Germany, Italy
Catalysis SL

Completed

Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma

Cutaneous Melanoma, Stage II | Cutaneous Melanoma, Stage III | Malignant Cutaneous Melanoma

Cuba
Targovax Oy

Completed

ONCOS-102 (Previously CGTG-102) for Therapy of Advanced Cancers

Malignant Solid Tumour

Finland
OncoSil Medical Limited

Recruiting

FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma (TRIPP-FFX)

Locally Advanced Pancreatic Cancer

Spain, Belgium, United Kingdom, Italy, Australia
Clinical Research Organization, Dhaka, Bangladesh

Unknown

Safety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular Carcinoma

Quality of Life

Bangladesh
GlaxoSmithKline

Completed

A Clinical Study to Evaluate the Efficacy of Three Dry Mouth Relief Products Versus Water

Xerostomia
OncoSec Medical Incorporated

Completed

Trial of pIL-12 Electroporation Malignant Melanoma (IL-12MEL)

Melanoma

United States
Transgene

Terminated

Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.

Colorectal Neoplasm | Digestive System Neoplasm

France, Spain, Belgium
Ashish Shah
National Cancer Institute (NCI); Denovo Biopharma LLC

Recruiting

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

High Grade Glioma | Anaplastic Astrocytoma

United States
Boston Scientific Corporation

Terminated

A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

Brain Neoplasms | Glioblastoma Multiforme

United States
FEMPHARMA Kft.

Completed

A Study of Incoxil Food Supplement in Female Patients With Stress Dominant Urinary Incontinence.

Urinary Incontinence

Hungary
St. Louis University

Completed

Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma (MasterPlan)

Follicular Lymphoma

United States
H. Lee Moffitt Cancer Center and Research Institute
OncoSec Medical Incorporated

Active, not recruiting

Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

Melanoma

United States
Assistance Publique - Hôpitaux de Paris
Transgene

Unknown

Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients (ONCOVIRAC)

Glioblastoma | Brain Cancer

France
Steven E. Coutre

Completed

Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia

Leukemia | Acute Lymphocytic Leukemia | Leukemia, Lymphocytic

United States
St. Jude Children's Research Hospital
National Cancer Institute (NCI)

Active, not recruiting

Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma

Retinoblastoma | Retinal Neoplasm

United States
Boston Scientific Corporation

Terminated

Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer

Esophageal Cancer | Squamous Cell Carcinoma | Adenocarcinoma of the Esophagus

United States, India, Czechia, Poland
Genzyme, a Sanofi Company

Completed

A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)

Lymphoblastic Leukemia, Acute, Childhood

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Pfizer; Oncovir, Inc.

Completed

Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100

Melanoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

Unspecified Childhood Solid Tumor, Protocol Specific

United States, Australia
Fidia Farmaceutici s.p.a.

Recruiting

Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Bladder Carcinoma in Situ (CIS)

United States, Spain, Italy, France, Poland
Fidia Farmaceutici s.p.a.

Completed

Study of ONCOFID-P-B™ (PACLITAXEL-HYALURONIC ACID)

Bladder Carcinoma in Situ (CIS)

Spain, Italy
Nina Bhardwaj
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaborators

Completed

Enhancement by Poly-ICLC During HIV-1 Infection (Poly-ICLC)

HIV-1 Infected Adults With Chronic HIV-1 Infection

United States
Acrotech Biopharma Inc.

Recruiting

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL (CRESCENDO)

Peripheral T Cell Lymphoma

United States
SOTIO a.s.

Terminated

A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer

Castration-resistant Prostate Cancer

Czechia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma

Brain Tumor | Central Nervous System Tumor

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma

Brain Tumors | Central Nervous System Tumors

United States, Canada, Netherlands, Puerto Rico, Switzerland, Australia
Boehringer Ingelheim

Terminated

Metamizol for the Treatment of Neoplastic Chronic Pain

Pain
Sichuan University

Unknown

Ruxolitinib Plus LVP in Patients With R/R ETP-ALL

Acute T Cell Leukemia
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

Classical Hodgkin Lymphoma

China
Children's Hospital Medical Center, Cincinnati

Withdrawn

Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma (RELRB1)

Retinoblastoma

United States
Targovax Oy

Completed

A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade

Advanced or Unresectable Melanoma Progressing After PD1 Blockade

United States, Norway

Search clinical trials for: OncoSil

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations